期刊文献+

抗凋亡机制与卵巢癌耐药的研究进展 被引量:1

下载PDF
导出
摘要 化疗在卵巢恶性肿瘤治疗中占重要地位,但抗肿瘤药物的疗效常因肿瘤细胞耐药而受限,耐药机理除传统耐药机制外还包括细胞对药物摄取与转运的改变,非特异的胞浆防卫系统及DNA分子修复系统改变等。实验已证实,抗凋亡机制在肿瘤细胞耐药中起更重要作用。综述近年文献中抗凋亡机制与卵巢癌耐药关系的研究。
作者 于利利
出处 《国外医学(妇产科学分册)》 2002年第4期201-204,共4页 Foreign Medical Sciences(Obstet Gynecol Fascicle)
  • 相关文献

参考文献20

  • 1Hannun YA.Apoptosis and dilemma of cancer chemotherapy.Blood,1997,89:1845-1853 被引量:1
  • 2El-Deity WS,Harper JW,O'Connor PM,et al.WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.Cancer Res,1994,54(5):1169-1174 被引量:1
  • 3Miyashita T,krajewski S,Krajewska M,et al.Tumor suppressor p53 is a regulator of bel-2 and bax in gene espression in vitro and in vivo.Oncogene,1994,9(6): 1799-1805 被引量:1
  • 4Perego P,Glarola M,Righrttisc,et al.Association between cisplatin resistance and mutation of p53gene and reduced bax expression in ovarian carcinoma cell systems.Cancer Res,1996,56(3):556-562 被引量:1
  • 5Siddik ZH,Mims B,Lozano G,et al.Independent pathways of p53 induction by cisplatin and ⅹ-rays in a cisplatin-resistant ovarian tumor cell line.Cancer Res,1998,58(4):698-703 被引量:1
  • 6Vaisman A,Varchenko M,Said I,et al.Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity.Cytometry,1997,27(1):54-64 被引量:1
  • 7Shelling AN,Cooke IE,Ganesan TS.The genetic analysis of ovarian cancer.Br J Cancer,1995,72(3):521-527 被引量:1
  • 8Reles A,Wen WH,Schmider A.Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.Clin Cancer Res,2001,7(10):2984-2997 被引量:1
  • 9Kigawa J,Sato S,Shimada M,et al.Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.Gynecol Oncol,2002,84 (2):210-215 被引量:1
  • 10Haldar S,Basu A,Groce CM.bcl-2 is the guardian of microtubule integrity.Cancer Res,1997,57(2):229-233 被引量:1

同被引文献18

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部